» Articles » PMID: 39827251

A Dual-mode Biosensor for MicroRNA Detection Based on DNA Tetrahedron-gated Nanochannels

Overview
Journal Mikrochim Acta
Date 2025 Jan 18
PMID 39827251
Authors
Affiliations
Soon will be listed here.
Abstract

A biosensor based on solid-state nanochannels of anodic aluminum oxide (AAO) membrane for both electrochemical and naked-eye detection of microRNA-31 (MiR-31) is proposed. For this purpose, MoS nanosheets, which possess different adsorption capabilities to single-stranded and double-stranded nucleic acids, are deposited onto the top surface of the AAO membrane. Moreover, multi-functional DNA nanostructure have been designed by linking a G-rich sequence for folding to a G-quadruplex at three vertices and a complementary sequence of MiR-31 at the other one vertex of a DNA tetrahedron. In the absence of MiR-31, the tetrahedron DNAzyme probe formed after the addition of hemin can mediate the deposition of insoluble on MoS/AAO, which not only enables the color change of the membrane but also gates the transport of K[Fe(CN)] across the nanochannels. Therefore, the detection of MiR-31 is realized by both visual observation of the brown color and measuring the electrochemical redox current of [Fe(CN)]. Using this biosensor, a detection limit as low as 0.06 fM is achieved. The dual-mode detection method also exhibits good specificity, reproducibility, and stability, demonstrating potential application in the diagnosis of oral squamous cell carcinoma and other related biological purposes.

References
1.
Lin X, Wu W, Ying Y, Luo J, Xu X, Zheng L . MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma. Cell Death Discov. 2022; 8(1):140. PMC: 8964740. DOI: 10.1038/s41420-022-00948-z. View

2.
Liu C, Lin S, Yang C, Cheng H, Chang K . Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck. 2011; 34(2):219-24. DOI: 10.1002/hed.21713. View

3.
Lu Z, He Q, Liang J, Li W, Su Q, Chen Z . miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer. Mol Ther Nucleic Acids. 2019; 16:471-480. PMC: 6495075. DOI: 10.1016/j.omtn.2019.03.012. View

4.
Schwarzkopf M, Pierce N . Multiplexed miRNA northern blots via hybridization chain reaction. Nucleic Acids Res. 2016; 44(15):e129. PMC: 5009741. DOI: 10.1093/nar/gkw503. View

5.
Duan D, Zheng K, Shen Y, Cao R, Jiang L, Lu Z . Label-free high-throughput microRNA expression profiling from total RNA. Nucleic Acids Res. 2011; 39(22):e154. PMC: 3239174. DOI: 10.1093/nar/gkr774. View